ZBIO
Zenas BioPharma, Inc.
27.80$
-1.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | – | – | – | 100.0% | 100.0% | – | – | 100.0% | – | 100.0% | 100.0% | |
| 0.1% | – | – | – | – | 0.7% | 0.2% | – | – | 557.2% | – | – | – | |
| 100.0% | – | – | – | – | 100.0% | 100.0% | – | – | -557.2% | – | 100.0% | -543.0% | |
| 18.7% | – | – | – | – | 983.1% | 349.2% | – | – | 2,223.9% | – | 6,291.3% | 3,455.9% | |
| 10.0% | – | – | – | – | 229.3% | 124.2% | – | – | 170.9% | – | 1,574.6% | 572.0% | |
| 28.8% | – | – | – | – | 1,212.5% | 473.3% | – | – | 1,822.6% | – | 10,865.9% | 3,780.4% | |
| 71.2% | – | – | – | – | -1,112.5% | -373.3% | – | – | -2,379.8% | – | -10,765.9% | -4,323.4% | |
| – | – | – | – | – | – | 0.0% | – | – | – | – | 1,030.2% | – | |
| 71.2% | – | – | – | – | -1,043.5% | -337.8% | – | – | -2,403.4% | – | -11,134.2% | -4,401.5% | |
| – | – | – | – | – | 8.6% | -2.1% | – | – | 1.1% | – | 11.4% | – | |
| 71.2% | – | – | – | – | -1,052.1% | -335.7% | – | – | -2,404.4% | – | -11,145.6% | -4,403.5% | |
| 71.3% | – | – | – | – | -1,042.8% | -337.6% | – | – | -2,304.1% | – | -10,103.6% | -4,157.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.